Intellia Therapeutics, Inc. (NTLA): Weighted Average Diluted Shares
108.38M
Year ended 2025-12-31
+12.1%
3-year compound annual growth
+14.1%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 108.38M | +9.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 98.85M | +11.4% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 88.77M | +15.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 76.97M | +8.6% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | 70.89M | +26.6% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | 55.99M | n/a | 2023-02-23, From 2020-01-01 |